inflammatory Archives

HUMAN MEDICINES EUROPEAN PUBLIC ASSESSMENT REPORT (EPAR): RITEMVIA, RITUXIMAB, LYMPHOMA, NON-HODGKIN,MICROSCOPIC POLYANGIITIS,WEGENER GRANULOMATOSIS, DATE OF AUTHORISATION: 13/07/2017, REVISION: 8, STATUS: AUTHORISED

Redazione11 Febbraio 2021

by Redazione11 Febbraio 202106

(AGENPARL) – LONDON (UNITED KINGDOM), gio 11 febbraio 2021 Ritemvia is a medicine used to treat the following blood cancers and inflammatory conditions: follicular lymphoma and diffuse large B cell non-Hodgkin’s lymphoma (two types of non-Hodgkin’s lymphoma, a blood cancer); granulomatosis with polyangiitis (GPA or Wegener’s granulomatosis) and microscopic polyangiitis......

SESAMIN PROTECTS AGAINST DSS-INDUCED COLITIS IN MICE BY INHIBITING NF-κB AND MAPK SIGNALING PATHWAYS

Redazione27 Gennaio 2021

by Redazione27 Gennaio 202100

(AGENPARL) – LONDON (UNITED KINGDOM), mer 27 gennaio 2021 Objective: To investigate the protective effects and mechanisms of sesamin (SES) on dextran sulfate sodium (DSS)-induced experimental colitis in mice. Methods: SES (50, 100, and 200 mg kg−1) were orally administered to C57BL/6 male mice after DSS instillation. The anti-inflammatory effect......

GUT MICROBIOTA REVEALS WHETHER DRUG THERAPIES WORK IN INFLAMMATORY BOWEL DISEASES

Redazione27 Gennaio 2021

by Redazione27 Gennaio 202103

(AGENPARL) – WORCESTER (MASSACHUSETTS), mar 26 gennaio 2021 The prevalence of inflammatory bowel diseases has significantly increased both in Finland and globally. These disorders cannot be entirely cured. Instead, they are treated with anti-inflammatory drugs and, at times, through surgery. If conventional drug therapies based on anti-inflammatory drugs are ineffective,......

EXERCISING MUSCLE COMBATS CHRONIC INFLAMMATION ON ITS OWN

Redazione24 Gennaio 2021

by Redazione24 Gennaio 202103

(AGENPARL) – WORCESTER (MASSACHUSETTS), dom 24 gennaio 2021 Biomedical engineers at Duke University have demonstrated that human muscle has an innate ability to ward off the damaging effects of chronic inflammation when exercised. The discovery was made possible through the use of lab-grown, engineered human muscle, demonstrating the potential power......

NSAIDS MIGHT EXACERBATE OR SUPPRESS COVID-19 DEPENDING ON TIMING, MOUSE STUDY SUGGESTS

Redazione23 Gennaio 2021

by Redazione23 Gennaio 202104

(AGENPARL) – WORCESTER (MASSACHUSETTS), sab 23 gennaio 2021 Washington, DC – January 22, 2021 – New research shows that non-steroidal anti-inflammatory drugs (NSAIDs) reduced both antibody and inflammatory responses to SARS-CoV-2 infection in mice. The study appears this week in the Journal of Virology, a publication of the American Society......

POTENTIAL COVID-19 DRUG IS SUCCESSFUL IN LAB STUDY

Redazione20 Gennaio 2021

by Redazione20 Gennaio 202104

(AGENPARL) – WORCESTER (MASSACHUSETTS), mer 20 gennaio 2021 A new therapy developed by researchers at Rush University Medical Center is showing success as a way to prevent COVID-19 symptoms in mice. In a study published in the Journal of Neuroimmune Pharmacology, mouse models with COVID-19 showed positive results when a......

RUSH RESEARCHERS DEMONSTRATE SUCCESS WITH NEW THERAPY FOR COVID-19

Redazione20 Gennaio 2021

by Redazione20 Gennaio 202101

(AGENPARL) – WORCESTER (MASSACHUSETTS), mer 20 gennaio 2021 A new therapy developed by researchers at Rush University Medical Center is showing success as a way to prevent COVID-19 symptoms in mice. In a study published in the Journal of Neuroimmune Pharmacology, mouse models with COVID-19 showed positive results when a......

MODERATING CELLULAR INFLAMMATION USING 2-DIMENSIONAL TITANIUM CARBIDE MXENE AND GRAPHENE VARIANTS

Redazione9 Gennaio 2021

by Redazione9 Gennaio 202102

(AGENPARL) – LONDON (UNITED KINGDOM), sab 09 gennaio 2021 The effective control of microbial and metabolically derived biological toxins which negatively impact physical health remains a key challenge for the 21st century. 2-dimensional graphene and MXene nanomaterials are relatively new additions to the field of biomedical materials with superior external......

GALACTOOLIGOSACCHARIDES PRETREATMENT ALLEVIATE DAMAGES OF INTESTINAL BARRIER AND INFLAMMATORY RESPONSES IN LPS-CHALLENGED MICE

Redazione4 Gennaio 2021

by Redazione4 Gennaio 202101

(AGENPARL) – LONDON (UNITED KINGDOM), lun 04 gennaio 2021 Galactooligosaccharides (GOS) have been identified as beneficial prebiotics to animals and human being. Most studies focused on the effect of GOS on hindgut populated with abundant of microbes. However, few researches conducted on the small intestine, and many results are inconsistent......

POTENTIAL NEW RX STRATEGY FOR STROKE

Redazione30 Dicembre 2020

by Redazione30 Dicembre 202002

(AGENPARL) – WORCESTER (MASSACHUSETTS), mer 30 dicembre 2020 Research conducted at LSU Health New Orleans Neuroscience Center of Excellence reports that a combination of an LSU Health-patented drug and selected DHA derivatives is more effective in protecting brain cells and increasing recovery after stroke than a single drug. Nicolas Bazan,......

SAN SABA, LONTANO DAL CLAMORE, NEL SILENZIO

CORLEONE, PENNISI:“UN SALTO INDIETRO. NON CI FAREMO INTIMIDIRE”

GOVERNO, ATTESA PER OGGI LA FIRMA DEL NUOVO DPCM ANTI-COVID

APPLY TO THE ATTORNEY GENERAL’S CIVIL PANEL COUNSEL – LONDON A, B…

REGISTER FOR THE 2021 INTERNATIONAL CHEMICAL WEAPONS DEMILITARISATION CONFERENCE

INAIL: GRIBAUDO (PD), DONNE PAGATE MENO E PIù ESPOSTE AL COVID

+++CORTE COSTITUZIONALE: L’AGENDA DEI LAVORI DEL 9 E 10 MARZO 2021+++

MYANMAR: IN GINOCCHIO PER LA PACE

P.DE LUCA (PD): RITARDI CASE FARMACEUTICHE INACCETTABILI. PREVEDERE SOSPENSIONE TEMPORANEA BREVETTI

VEHICLE FREIGHT COMPANY WOUND UP FOR FAILING TO DELIVER GOODS

inflammatory